Latest news with #Bartels
Yahoo
14-05-2025
- Business
- Yahoo
Annual Colossal Sale kicks off at Evangel University
SPRINGFIELD, Mo. — The Evangel University Advocates are hosting its annual Colossal Sale this week to raise money to benefit Evangel students and staff. The annual fundraising sale is made up of donated items and items left behind by students after graduation and the end of classes for the summer. Featuring everything from furniture and clothes to books and games, there is a wide variety of items to choose from. 'The list is endless, but the quality is very good,' said Robert Bartels, a volunteer at the event and the Human Resources Director at Evangel. 'I've been very pleased with the amount of goods that we've had, but the quality of them as well.' David Cameron selected as new Springfield city manager Bartels says they had a line outside the door waiting to get in and see what items this year's sale had in store. There are plenty of volunteers to help you shop and even carry your finds back to your car. 'Everybody is super nice and helpful here,' said Katelyn Hammons, who was shopping at the sale. 'If they notice your hands are getting too full, they'll come and offer to hold items for you. And everything's super clean and organized too, which is nice.' Hammons is an Evangel alumna and comes every year with her sister. She says there are always great finds, and it supports the college she graduated from. 'I have a whole bin over there that they're holding. I don't even remember how much is in there right now,' Hammons said. 'It's a really good selection of items. And if you can't get out and garage sale like on the weekends, this is nice. Like a one-stop kind of location.' East Elementary named one of eight Missouri Gold Star Schools Evangel University Advocates helps fill in the gaps for students and staff. In the past, they helped buy a new kiln for the art department, contributed funds to upgrade the student sand volleyball court, and provided additional materials for some classes. 'We offer grants to our own departments for different projects that they'd like to do stuff that's not in the budget that they'd love to accomplish,' Bartels said. 'Sometimes it's renovation, sometimes it's equipment, sometimes it's putting up a wall where it didn't belong before. So there's all different kinds of things that we've done.' The Colossal Sale started in 1964 and took a break in 2014, but was revived in 2019 and has been going strong since then. Bartels tells me they couldn't do the sale without the help of their many volunteers. The sale will be open to the public: Wednesday, May 14, 8 a.m. to 5 p.m. Thursday, May 15, 8 a.m. to 5 p.m. Friday, May 16, 8 a.m. to 5 p.m. Saturday, May 17, 9 a.m. to noon Friday, all items will be half-priced, and on Saturday, shoppers can fill a provided paper bag with items for $7. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Medscape
06-05-2025
- Health
- Medscape
Novel Shoes May Cut Low Back Pain, Delay Knee Arthroplasty
INCHEON, South Korea — A shoe-based biomechanical intervention worn for a short time each day may achieve greater improvements in low back pain and greater reductions in the risk for total knee replacement surgery than standard physical therapy, according to two studies presented at the World Congress on Osteoarthritis (OARSI) 2025 Annual Meeting. 'If you've ever watched somebody who has pain — whether it's knee pain, hip pain, back pain — they walk a little strange,' said presenter Matthew Bartels, MD, MPH, director of Rehabilitation Medicine and professor of physical medicine and rehabilitation at Montefiore Medical Center and Albert Einstein College of Medicine in New York City. But walking differently to compensate for pain can actually make the problem worse, directing the ground force through the affected area of the body, whether the knee or lower back. Bartels presented data from two studies of the US Food and Drug Administration–cleared shoe-based intervention, which 'alters the foot's pressure points to reduce loads, minimize symptoms, and promote neuromuscular control training using adjustable, convex pods under the sole,' according to the researchers. The first was a randomized controlled trial comparing the effects of the intervention and standard physical therapy on pain in 162 patients with low back pain. Participants were randomized in a 2:1 ratio either to the shoe-based intervention from AposHealth — which was individually tailored and calibrated six times over 1 year — or to standard physical therapy. In addition to being presented at OARSI, the trial was recently published in Global Spine Journal . At 1 year after randomization, those who used the shoe-based intervention reported a significantly greater mean 3.5-point reduction in their pain scores, as measured on a 10-point numeric rating scale, compared with a mean 1.8-point reduction in those who received physical therapy. The participants in the intervention also reported better secondary outcomes, including greater improvements in their Patient-Reported Outcomes Measurement Information System function scores, gait speed, and overall quality of life. Bartels told Medscape Medical News that the intervention was likely to have greater compliance than physical therapy because patients could use it at home for as little as 15 minutes at a time and feel the benefits pretty quickly. 'We all know that if you have knee or back pain, physical therapy will make you better, but the problem is, people don't keep the exercises up,' he said. 'This is a treatment that you put the shoes on, and you just wear them doing normal activities for a period, so it doesn't take time out of your day.' Bartels' own experience of his patients using the shoes was that even if patients did stop wearing them once their symptoms improved, they often started using them again if their symptoms returned, 'so they kind of self-dose,' he said. The second study Bartels presented was a poster detailing the results of a retrospective registry review of 95 patients with knee osteoarthritis (OA) who had been prescribed the shoe intervention after exhausting other nonsurgical options to see whether it was associated with a reduction in the likelihood of total knee replacement surgery. The study was also published last year in the Journal of Musculoskeletal Research . After an average follow-up time of 5.6 years, 12.6% of the patients using the shoe had undergone total knee replacement compared with 34.3% of a control group of patients from the same period who received traditional physical therapy. 'Increased use of biomechanical intervention to treat knee OA may help reduce some of the burden on healthcare and society associated with end-stage knee OA by delaying or avoiding surgery,' the researchers wrote. Commenting on the two studies, physical therapist and epidemiologist Garrett Bullock, PhD, DPT, of Wake Forest University School of Medicine, Winston-Salem, North Carolina, said, 'For a specific type of patient that has tried exercise interventions, has tried medication interventions, and a combination of both, that has a decent amount of physical activity, it may be something to explore, particularly to maintain neutral balance or create a better line through the foot.' Bullock told Medscape Medical News that there was always a risk that patients wouldn't adhere to physical therapy, so an intervention that provided education and the tools for self-efficacy could help them to manage their own symptoms.
CNBC
02-05-2025
- Business
- CNBC
The stock market rebound is now a historic winning streak
A turbulent period for stocks around new tariff policies from the White House has remarkably given way to Wall Street's longest winning streak in 20 years. The S & P 500 rose again on Friday, notching a ninth straight positive session for the first time Nov. 5, 2004. The index also traded above its April 2 close for the first time since the major tariff announcement a month ago. .SPX 3M mountain The S & P 500 has risen for nine straight sessions, hitting its highest level in a month on Friday. Not to be outdone, the Dow Jones Industrial Average also cashed a ninth straight winning day, its longest streak in more than a year. In London, the winning streak for the FTSE 100 index hit a record of 15 consecutive days . The rally doesn't appear to be a weak one either, at least according to technical experts. Mary Ann Bartels, chief investment strategist at Sanctuary Wealth, said Friday on CNBC's " Money Movers " that the S & P 500's winning streak seems to be repairing some technical damage caused in early April. "The breadth of the market has been really strong, and a number of my breadth indicators are giving buy signals . Volume is not bad, but it's decent enough, and if we can go up and test resistance near the 200-day moving average near 5,745, or even get above it around 5,800, there's a chance we don't have to go down and test those awful lows at 4,835," Bartels said. There have been some positive news and data points to help support this rally. The April jobs report came in better than expected, and there have been some positive signs about potential trade negotiations between China and the U.S. But even against a positive backdrop, this move for the stock market stands out as being unusual. "We will stick our neck out to say we won't go up every day as we have since last Monday. And we will even go on to say the S & P 50-day around 5700, pretty much where we are now, is a logical stalling point — even bull markets don't go straight up," Wellington Shields technical analyst Frank Gretz said in a note to clients Friday. Of course, not every data point suggests that the economy and markets are in great shape, such as Apple's warning of $900 million in tariff-related costs for the current quarter. That has led to an uneasy combination of a historic winning streak at the same time that Wall Street analysts and economists are dialing back their expectations for growth. "If half of your brain is technical and half fundamental … you probably have a migraine," Gretz said.
Yahoo
01-05-2025
- Automotive
- Yahoo
Exceptionally Original 1958 BMW 507 Roadster Headlines Villa d'Este Auction
⚡️ Read the full article on Motorious One of the most iconic sports cars of the postwar era, a remarkably original 1958 BMW 507 Series II Roadster, will be offered at the Concorso d'Eleganza Villa d'Este Auction on May 24, 2025, by Broad Arrow Auctions. With an estimated value between €2,000,000 and €2,300,000, the car stands out not only for its rarity—just 252 units were built—but for its extraordinary provenance and preservation. Chassis number 70127 was delivered new in April 1958 to Wilhelm Bartels of Braunschweig, Germany, who gifted it to his 17-year-old wife, Elisabeth. The Federweiss-painted roadster, with a two-tone black and white interior, remained in the Bartels family for an astonishing 46 years. During that time, it was consistently maintained by the same mechanic, who also carried out a front disc brake upgrade—a testament to the meticulous care it received. Regarded as a design triumph by Albrecht Graf von Goertz, the 507's sculpted aluminum body, paired with a 3.2-liter V8 and four-speed manual transmission, aimed to rival the Mercedes-Benz 300 SL. However, its steep price tag—more than twice its projected cost—led to limited production and made it a choice only for the elite. Celebrity owners included Elvis Presley, Alain Delon, and Ursula Andress. Following its sale by the Bartels family in 2004, the car passed to Horst Kölpin, who preserved its condition while respecting its legacy. In 2018, it entered the hands of only its third owner. Remarkably, just seven kilometers have been added since that transition. Accompanied by its original German registration document and factory-issued owner's manual, this unrestored example is eligible for premier concours and driving events around the world. It offers collectors a rare opportunity to acquire one of the most desirable and historically significant BMWs ever built—one with a story as elegant as its design. See it here.
Globe and Mail
04-04-2025
- Business
- Globe and Mail
Strategist Warns of 20% S&P 500 Plunge amid Trump's Tariff Shock
The Trump administration's newly imposed tariffs have sent shockwaves through the financial markets. Sanctuary Wealth's chief investment strategist, Mary Ann Bartels, described the proposal as a 'worst-case scenario' that was not priced into the market. Looking ahead, she predicts that the S&P 500 Index (SPX) could face a decline of up to 20%. Don't Miss Our End of Quarter Offers: Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks. Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter. The tariffs, which include a minimum 10% baseline levy on imports and rates as high as 49% on goods from specific countries, have already rattled markets. The S&P 500 fell over 4% on Thursday morning, officially entering correction territory. Bartels noted that if the index fails to hold the critical 5,500 support level, investors could see further declines, potentially bottoming between 5,200 and 5,400. Tariffs Might Trigger Global Recession The proposed tariffs could hurt the economy, and Bartels warns they might cause a slowdown or even a recession in the U.S. and worldwide. She believes the administration may be aiming to slow the economy to pressure the Federal Reserve to lower interest rates and facilitate debt restructuring. Importantly, the March Jobs report, due today, is seen as a key indicator for the Fed's next move. A weakening labor market could prompt the Fed to cut interest rates sooner than anticipated. Investors Could Eye ETFs During Tariff Chaos This tariff-induced market turmoil reflects the potential for significant economic and financial fallouts, prompting investors to adopt a cautious stance. Thus, investors could closely monitor some market-tracking ETFs such as (SPY), (QQQ), (DIA), (VOO), (IVV), and (IWM). According to the TipRanks ETF Comparison tool, analysts see the most upside potential in the IWM ETF of 45.9%, followed by the QQ ETF of 33.3%. All other ETFs are also expected to surge over 20% in the next 12 months. Disclaimer & Disclosure Report an Issue This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
